15-235 - Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the Membranes
Status: openA Randomized Double-Blinded Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids on Neonatal Outcome in Patients with Prelabor Premature Rupture of Membranes
Treatment for Premature Rupture of Membranes
Description
This trial hopes to prospectively evaluate the impact of one versus two courses of antenatal steroids on the incidence of major neonatal morbidity in pregnant women with pre-labor premature rupture of the membranes. IRB Number 15-235
Sponsors
This trial is sponsored by Obstetrix Medical Group.Interested in Clinical Trial?
Contact the Clinical Trial Coordinator
If you have questions get in touch with this Clinical Trial’s Coordinator by phone at 251-415-1598 or by email at marmistead@health.southalabama.edu.
Providers Associated With This Trial
Principle Investigator
![Susan Baker]()
View ProfileSusan L. Baker, M.D.Maternal-Fetal PhysicianDirector of Maternal Fetal Medicine Division; Associate Professor of Obstetrics and Gynecology
This link will open in a new tab or window.